Monday (28/10), located at The Margo Hotel Depok, the Research Center for Biomedical Engineering (RCBE) of the Faculty of Engineering, Universitas Indonesia again held the ninth annual International Symposium on Biomedical Engineering or called the 9thISBE 2024.
This year’s ISBE carries the theme “Unleashing the Impact in Biomedical Engineering“, ISBE 2024 is again a place to gather and share research results and publications of researchers in the field of biomedical engineering. This year, ISBE was held in collaboration with Universiti Teknologi MARA, Malaysia
The event began with remarks from the Chairman of ISBE 2024, Dr. Kenny Lischer, S.T., M.T., Ph.D., then the Head of the FTUI Engineering Interdisciplinary Research Unit, Prof. Dr. Ir. Widodo Wahyu Purwanto, DEA., as well as opening ISBE 2024.
“The theme of Unleashing the Impact in Biomedical Engineering at this year’s ISBE is very relevant to the challenges and opportunities in the field of biomedical engineering today. The conference provides a space for academics, researchers, and practitioners to share innovative findings that will not only broaden our horizons about health technology, but also open up broader collaboration opportunities. With the increasing importance of the contribution of biomedical techniques in improving the quality of life, we hope that this symposium can be a driving force in presenting real and sustainable solutions for the medical world,” said Prof. Dr. Heri Hermansyah, ST., M.Eng., IPU, Dean of FTUI, on a separate occasion.
In the Keynote Session, there were three keynote speakers, namely Prof. Peter V.S. Lee from the University of Melbourne, with the topic: “A patient-centric framework for developing safer 3D printed personalised medical implants”; Prof. Mohammed Rafiq bin Dato’ Abdul Kadir from Universiti Teknologi MARA Malaysia presented the topic: “Unleashing the Impact in Biomedical Engineering”; and Dr. Sugeng Supriadi from the Faculty of Engineering, University of Indonesia with the topic: “Innovation in Biomaterial Products: Implants with Ecosystem”
Keynote speaker 1, Peter V.S. Lee from the University of Melbourne, discussed developments in the manufacture of personalized medical implants using computer-aided engineering, additive manufacturing, and antibacterial coating. Although there have been advances in customization for orthopedics and maxillofacial surgery, major challenges still exist in terms of commercialization and widespread use of personalized implants. Currently, there is no clear framework or methodology to support the use and increase the success rate of personalized implants. Lee proposed a “Measure-Model-Manufacture-Manage (4M)” framework that leverages patient biomechanical measurements to build models that can be used to optimize implant designs before they are 3D printed and implemented. The framework aims to improve patient management and outcomes through a comprehensive approach.
Keynote speaker 2, Prof. Mohammed Rafiq from Universiti Teknologi MARA Malaysia explored advances in the field of biomedical engineering, especially in finite element computational biomechanics, advanced biomaterials, biomimicry, and the transformational role of artificial intelligence (AI) in healthcare. Computational biomechanics allows modeling and simulation of biological tissue behavior, aiding in the design of medical devices and surgical procedures. Coupled with advanced biomaterials, such as biodegradable polymers and nanocomposites, this approach enables the development of next-generation implants that mimic the mechanical properties of human tissue. Biomimetic principles and AI-driven computational tools are also driving healthcare personalization, optimizing patient outcomes and medical research.
Keynote speaker 3, Dr. Sugeng Supriadi from the University of Indonesia researched the development of innovative orthopedic implants using an alloy of titanium and magnesium. The alloy is known for its biocompatibility, strength, and corrosion resistance, making it ideal for long-term medical applications. Magnesium alloys also have great potential for degradable implants, reducing the need for secondary surgery. The study emphasizes the importance of following the ISO 13485 standard during design, manufacturing, and testing to ensure the safety and quality of medical devices. 3D printing technology is also cited as a promising innovation for the production of highly customized implants, especially in the case of oncology. Collaboration in Indonesia’s orthopedic implant ecosystem is identified as key to successful product commercialization.
A total of 34 papers from participants from 4 countries, namely Indonesia, Malaysia, the Philippines and Japan, were presented in this conference. It is divided into 4 major topics, namely Medical Devices, Drug Delivery and Development. Biomaterial and Tissue Engineering, dan Clinical & Health Management. The paper presented will then go through a review and publication process in an international journal indexed by Scopus.
***
Public Communication Office
Faculty of Engineering, Universitas Indonesia
